Genetic and Metabolic Determinants of Plasma PCSK9 Levels-Reference-Cited by-同舟云学术

Genetic and Metabolic Determinants of Plasma PCSK9 Levels

Published:2009-07-01 Issue:7 Volume:94 Page:2537-2543
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Lakoski Susan G.¹,Lagace Thomas A.²,Cohen Jonathan C.¹,Horton Jay D.¹²,Hobbs Helen H.¹²³

Affiliation:

1. Donald W. Reynolds Cardiovascular Clinical Research Center, Departments of Internal Medicine (S.G.L., J.C.C., J.D.H., H.H.H.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9046

2. Molecular Genetics (T.A.L., J.D.H., H.H.H.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9046

3. The Howard Hughes Medical Institute (H.H.H.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9046

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/94/7/2537/9066373/jcem2537.pdf

Reference26 articles.

1. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.;Seidah;Proc Natl Acad Sci USA,2003

2. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.;Cohen;Nat Genet,2005

3. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.;Kotowski;Am J Hum Genet,2006

4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.;Abifadel;Nat Genet,2003

5. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.;Cohen;N Engl J Med,2006

Cited by 453 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Predictive Utility of Circulating PCSK9 Levels on Diabetic Retinopathy Stage;Current Eye Research;2024-07-31

2. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

3. Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review;Pharmaceuticals;2024-07-09

4. Assessment of serum proprotein convertase subtilisin/kexin type 9 in pediatric sepsis syndrome;Scientific Reports;2024-07-07

5. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes;Atherosclerosis;2024-07